What does it take to bridge groundbreaking science, clinical medicine and global biotech innovation?
Dr. Li-ming Gan is a physician scientist, professor and CEO of Ribocure Pharmaceuticals, where he leads the development of next-generation RNA therapeutics.
With more than 20 years of experience from AstraZeneca, where he held senior leadership roles in cardiovascular, renal and metabolism R&D, Li-Ming has been at the forefront of translating scientific discoveries into clinical breakthroughs.
Alongside his work in the pharmaceutical industry, he has continued his academic research work as supervisor and professor at the University of Gothenburg and clinical work at Ribocure clinic.
Today, through Ribocure, he is helping shape the future of innovative RNA-based therapies on a global scale.
In this episode we talk innovation, leadership and how to reach ikigai.
Learn more about Ribocure.
🎙️ Production credits
Guest: Li-ming Gan, CEO, Ribocure
Host: Jamie Smith
Editorial lead & episode development: Elin von Vultée Widtfelt
Post-production, sound & video: Nils Björquist
Artwork: Ella Smith Ygfeldt
Technical production support: JIRE Productions AB
Produced by Jamie Smith Communications AB
